What is the appropriate treatment for a Multiple Myeloma patient presenting with severe hypercalcemia?

• A. Dexamethasone
• B. Pamidronate
• C. Calcium Gluconate
• D. Furosemide

Answer: (B)

In the context of a patient with multiple myeloma who is experiencing severe hypercalcemia, the appropriate treatment is pamidronate. Hypercalcemia in this setting is often due to increased bone resorption caused by osteoclastic activity that is frequently heightened in multiple myeloma. Pamidronate, a bisphosphonate, is effective at inhibiting osteoclast activity, thereby reducing bone resorption and lowering serum calcium levels.

This treatment not only helps normalize calcium levels but can also alleviate some of the associated symptoms of hypercalcemia, such as weakness, confusion, and dehydration. Additionally, bisphosphonates like pamidronate are beneficial in managing skeletal complications associated with multiple myeloma, making this choice particularly suitable for a patient with both conditions.

While other treatments may have roles in addressing hypercalcemia, they do not directly manage the underlying cause linked with multiple myeloma in the same effective way as pamidronate does. For instance, dexamethasone can help manage multiple myeloma but is not specifically indicated for hypercalcemia, while furosemide might be employed in cases of volume overload due to hypercalcemia but does not address hypersensitivity directly. Calcium glucon